Over the past 12 months, 5 insiders at PUMA BIOTECHNOLOGY, INC. filed 11 open-market SEC Form 4 transactions on PBYI: 0 purchases worth $0 and 11 sales worth $1.0M. Insiders have been net sellers over this period. The most recent filing was on Jul 6, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 6, 26 | Alan H AuerbachPresident and CEO | SELL | 44.1K | $8.26 | $364K |
| Jul 6, 26 | Douglas M HuntSee Remarks | SELL | 8.5K | $8.26 | $70K |
| Jul 6, 26 | Maximo F NouguesChief Financial Officer | SELL | 9.4K | $8.26 | $78K |
| Jun 12, 26 | Allison Dorval | SELL | 11.6K | $7.20 | $84K |
| Jan 7, 26 | Alan H AuerbachPresident and CEO | SELL | 18.0K | $5.88 | $106K |
| Jan 7, 26 | Douglas M HuntSee Remarks | SELL | 5.0K | $5.88 | $29K |
| Jan 7, 26 | Maximo F NouguesChief Financial Officer | SELL | 6.4K | $5.88 | $38K |
| Jan 6, 26 | Alan H AuerbachPresident and CEO | SELL | 16.9K | $5.84 | $99K |
| Jan 6, 26 | Douglas M HuntSee Remarks | SELL | 4.0K | $5.84 | $23K |
| Jan 6, 26 | Maximo F NouguesChief Financial Officer | SELL | 4.5K | $5.84 | $27K |
| Nov 11, 25 | Michael Patrick MillerDirector | SELL | 20.0K | $4.86 | $97K |
| Jul 18, 25 | Alessandra CesanoDirector | SELL | 27.0K | $3.37 | $91K |
| Jul 9, 25 | Alan H AuerbachPresident and CEO | SELL | 21.6K | $3.54 | $76K |
| Jul 9, 25 | Douglas M HuntSee Remarks | SELL | 3.4K | $3.54 | $12K |
| Jul 9, 25 | Maximo F NouguesChief Financial Officer | SELL | 3.9K | $3.54 | $14K |
| Jul 8, 25 | Alan H AuerbachPresident and CEO | SELL | 25.6K | $3.53 | $90K |
| Jul 8, 25 | Douglas M HuntSee Remarks | SELL | 4.4K | $3.53 | $15K |
| Jul 8, 25 | Maximo F NouguesChief Financial Officer | SELL | 5.6K | $3.53 | $20K |
| Jun 13, 25 | Alessandra CesanoDirector | SELL | 12.2K | $3.40 | $41K |
| Jun 13, 25 | Allison DorvalDirector | SELL | 11.6K | $3.40 | $39K |
| Jun 13, 25 | Jay M MoyesDirector | SELL | 22.0K | $3.40 | $75K |
| Jun 13, 25 | Adrian SenderowiczDirector | SELL | 27.0K | $3.40 | $92K |
| Jun 13, 25 | Brian M StuglikDirector | SELL | 8.1K | $3.39 | $27K |
| Jun 13, 25 | Troy Edward WilsonDirector | SELL | 10.8K | $3.40 | $37K |
| Jan 2, 25 | Alan H AuerbachPresident and CEO | SELL | 33.8K | $3.15 | $107K |
| Jan 2, 25 | Douglas M HuntSee Remarks | SELL | 8.6K | $3.15 | $27K |
| Jan 2, 25 | Jeffrey Jerome LudwigChief Commercial Officer | SELL | 9.4K | $3.15 | $30K |
| Jan 2, 25 | Maximo F NouguesChief Financial Officer | SELL | 10.2K | $3.15 | $32K |
| Aug 12, 24 | Michael Patrick MillerDirector | SELL | 23.4K | $3.49 | $82K |
| Jul 17, 24 | Alan H AuerbachPresident and CEO | SELL | 21.9K | $3.70 | $81K |
| Jul 17, 24 | Douglas M HuntSee Remarks | SELL | 3.6K | $3.70 | $13K |
| Jul 17, 24 | Jeffrey Jerome LudwigChief Commercial Officer | SELL | 2.6K | $3.70 | $10K |
| Jul 17, 24 | Maximo F NouguesChief Financial Officer | SELL | 4.2K | $3.70 | $15K |
| Jul 2, 24 | Alan H AuerbachPresident and CEO | SELL | 18.9K | $3.27 | $62K |
| Jul 2, 24 | Douglas M HuntSee Remarks | SELL | 4.3K | $3.27 | $14K |
| Jul 2, 24 | Jeffrey Jerome LudwigChief Commercial Officer | SELL | 6.1K | $3.27 | $20K |
| Jul 2, 24 | Maximo F NouguesChief Financial Officer | SELL | 5.3K | $3.27 | $17K |
| Jun 13, 24 | Allison DorvalDirector | SELL | 11.0K | $3.37 | $37K |
| Jun 13, 24 | Jay M MoyesDirector | SELL | 22.0K | $3.34 | $73K |
| Jun 13, 24 | Adrian SenderowiczDirector | SELL | 27.0K | $3.33 | $90K |
| Jun 13, 24 | Brian M StuglikDirector | SELL | 9.9K | $3.39 | $34K |
| Jun 13, 24 | Troy Edward WilsonDirector | SELL | 27.0K | $3.33 | $90K |
| Jan 3, 24 | Alan H AuerbachPresident and CEO | SELL | 41.4K | $4.49 | $186K |
| Jan 3, 24 | Douglas M HuntSee Remarks | SELL | 8.4K | $4.49 | $38K |
| Jan 3, 24 | Jeffrey Jerome LudwigChief Commercial Officer | SELL | 13.0K | $4.49 | $58K |
| Jan 3, 24 | Maximo F NouguesChief Financial Officer | SELL | 15.7K | $4.49 | $70K |
| Jan 3, 24 | Alvin F WongChief Scientific Officer | SELL | 7.7K | $4.49 | $35K |
| Dec 4, 23 | Alvin F WongChief Scientific Officer | SELL | 280 | $3.76 | $1K |
| Nov 7, 23 | Michael Patrick MillerDirector | SELL | 25.0K | $2.83 | $71K |
| Jul 3, 23 | Alan H AuerbachPresident and CEO | SELL | 60.7K | $3.31 | $201K |
Over the past 12 months, insiders at PUMA BIOTECHNOLOGY, INC. filed 0 open-market purchases worth $0 and 11 sales worth $1.0M on PBYI, which makes them net sellers over the period. The most recent Form 4 was filed on Jul 6, 26.
5 different insiders at PUMA BIOTECHNOLOGY, INC. filed open-market SEC Form 4 transactions on PBYI over the last 12 months.
InsiderTape plots every PBYI insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every PUMA BIOTECHNOLOGY, INC. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →